At fertilization in mammals the sperm activates development of the oocyte by inducing a prolonged series of oscillations in the cytosolic free Ca 21 concentration. These data show that PLCz is a novel parthenogenetic stimulus for human oocytes and that it is unique in its ability to mimic the repetitive nature of the Ca 21 stimulus provided by the sperm during human fertilization.
Introduction
Mammalian oocytes are ovulated in a state of arrest at metaphase of the second meiotic division. During fertilization the sperm releases the oocyte from metaphase arrest and initiates development by inducing a series of repeated rises in the cytosolic free Ca 2þ concentration (Whittingham 1980 , Cuthbertson & Cobbold 1985 , Stricker 1999 . Such repeated rises in Ca 2þ , or Ca 2þ oscillations, occur at intervals of several minutes for the first few hours after sperm-oocyte interaction. These Ca 2þ oscillations have been observed during in vitro fertilization (IVF) in a range of mammalian species including oocytes from humans (Taylor et al. 1993) . In addition, in human and mouse oocytes prolonged Ca 2þ oscillations have also been demonstrated following intracytoplasmic sperm injection (ICSI; Tesarik & Sousa 1994 , Nakano et al. 1997 . The Ca 2þ oscillations seen in mammals appear to be both necessary and sufficient for the activation of development. In the mouse, for example, it has been shown that the Ca 2þ oscillations are necessary for secondpolar-body emission and pronuclear formation (Kline & Kline 1992) . The importance of Ca 2þ is also underlined by the finding that most of the treatments that cause the parthenogenetic activation of development in mammals are effective because they cause a marked rise in the cytosolic Ca 2þ concentration (Whittingham 1980 , Swann & Ozil 1994 . In mouse and domestic animal oocytes parthenogenetic activating agents such as ethanol, Ca 2þ ionophores and electrical-field stimulation cause a single and prolonged rise in Ca 2þ (Swann & Ozil 1994) . In mouse, and some other species, parthenogenetic activating agents such as Sr 2þ ions or thimerosal have been shown to cause Ca 2þ oscillations that are similar, but not identical, to those seen at fertilization (Kline & Kline 1992 , Cheek et al. 1993 .
The mechanism by which the sperm stimulates the Ca 2þ oscillations at fertilization is not fully resolved (Stricker 1999) . However, one theory is that the sperm introduces a protein factor into the egg cytosol after gamete fusion, and that this sperm factor protein initiates Ca 2þ release in the oocyte via the generation of inositol 1,4,5-trisphosphate (InsP 3 ; Swann et al. 2004) . This theory is supported by the finding that injecting cytosolic extracts from sperm can cause Ca 2þ oscillations in a range of different mammalian oocytes, including those from humans (Swann 1990 , Homa & Swann 1994 , Wu et al. 1997 . We recently demonstrated that mouse sperm possess a novel and specific isoform of phospholipase C (PLC) referred to as PLCz . PLCz was shown to be the protein present in the sperm extracts that is responsible for generating Ca 2þ release and InsP 3 production . Most critically it was demonstrated that PLCz is an effective mimic of the sperm because microinjection of complementary RNA (cRNA) encoding for PLCz into mouse oocytes causes Ca 2þ oscillations identical to those seen during fertilization. Injection of cRNA for PLCz also leads to egg activation and development to the blastocyst stage in the mouse . As well as mice, both humans and monkeys have been shown to possess a sperm-specific PLCz . Previous work suggested that the sperm factor protein was not species specific and, consistent with this, we found that injection of cRNA for the human or monkey isoforms of PLCz is able to cause Ca 2þ oscillations in mouse oocytes and stimulate embryo development up to the blastocyst stage at similar rates to those seen after in vivo fertilization . However, the effect of PLCz in human oocytes has not previously been reported.
Like other mammals human oocytes can also be parthenogenetically activated by stimuli that elevate Ca 2þ levels. Calcium ionophores such A23187 have been shown to cause both fresh and aged oocytes to undergo pronuclear formation and begin early cleavage divisions (Winston et al. 1991) . However, some studies have found that Ca 2þ ionophore alone does not reliably activate human oocytes (Balakier & Casper 1993 , Rinaudo et al. 1997 . So the most common current activation protocols combine Ca 2þ ionophore with protein synthesis or protein kinase inhibitors such as 6-dimethyl aminopurine (6-DMAP) or puromycin (Cibelli et al. 2001 , Nakagawa et al. 2001 , Lin et al. 2003 . These combination protocols have proved effective in stimulating human oocytes to form pronuclei, but the success rates of subsequent preimplantation development are still poor compared with embryo development after fertilization. In order to try and improve activation and development after parthenogenesis, attempts have been made to use stimuli that mimic IVF in causing repetitive Ca 2þ increases. Data in mouse and rabbit oocytes that were exposed to repeated electrical-field pulses have suggested that repeated rises in Ca 2þ can improve activation rates, and subsequent development, compared with stimuli that cause a single Ca 2þ increase (Ozil 1990 , Ozil & Huneau 2001 . Limited application of this technology has suggested that the repetitive stimuli may also be useful in activating human oocytes (Zhang et al. 1999) . In this study we demonstrate that microinjection of cRNA encoding human PLCz protein can cause a prolonged series of Ca 2þ oscillations in aged human oocytes that have failed to fertilize during IVF or ICSI. The induction of Ca 2þ oscillations by PLCz can also lead to parthenogenetic activation up to the blastocyst stage.
Materials and Methods

Obtaining and handling of human oocytes
Human oocytes were obtained from patients whose gametes had failed to fertilize following conventional IVF or ICSI. Ethical approval for the project was obtained from St Thomas's Hospital Local Research Ethics Committee and from the Human Fertilization and Embryology Authority who issued a licence for the work (R0147). Consent for the use of unfertilized oocytes was obtained from patients before starting their treatment. For treatment the patients underwent pituitary downregulation and controlled ovarian hyperstimulation using gonadotrophins. Ovarian stimulation was achieved using a daily dose of 150-450 IU of recombinant follicle-stimulating hormone (Gonal F; Serono Laboratories, Welwyn Garden City, Herts, UK; or Puregon; Organon, Cambridge, UK). Human chorionic gonadotrophin, 10 000 IU (Profasi from Serono Laboratories or Pregnyl from Organon), was administered when at least three follicles had reached a mean diameter of 18 mm or more. Transvaginal follicular aspiration was performed 34 -36 h after human chorionic gonadotrophin injection and 3-6 h later oocytes were prepared for IVF or ICSI dependent upon earlier semen analysis. Following IVF insemination or ICSI oocytes were cultured overnight and checked for signs of fertilization 19 -20 h later. Only those oocytes that appeared to be at metaphase II or I and that showed no signs of fertilization were used for the project. Such unfertilized oocytes were transferred from the Assisted Conception Unit at Guy's Hospital to laboratories at University College London and microinjected within the next 1 -2 h. Unless otherwise stated, all manipulations in the laboratory were carried out on ooyctes in Hepes/KSOM (HKSOM) medium .
In experiments where Ca 2þ was monitored oocytes were injected with solutions containing various concentrations of PLCz cRNA and 1 mM Oregon Green BAPTA dextran (Molecular Probes, Eugene, OR, USA) in a buffered salt solution (120 mM KCl/20 mM Hepes, pH 7.4) that had been treated with Chelex 100 beads (Sigma) to remove divalent cations. In developmental experiments where Ca 2þ was not monitored the Oregon Green BAPTA dextran was omitted from the injection buffer. cRNA encoding the 608-amino-acid sequence of the human form of PLCz was prepared as described previously . The cRNA was stored in aliquots at 2 80 8C until being thawed immediately prior to injection. For injection the oocytes were placed on a Nikon Diaphot stage and microinjected by application of brief pressure pulses as described previously (Swann 1990) . The injection was between 3 and 5% of the oocyte's total volume. For Ca 2þ measurements oocytes were immediately transferred to a chamber of approximately 1 ml containing HKSOM medium and fluorescence monitored as described below. For separate developmental studies the oocytes were placed in 2 mM cytochalasin D (Sigma) for approximately 2 h to prevent second-polar-body extrusion and then cultured in 20 ml drops of Sydney IVF cleavage medium (COOK) under mineral oil (Sigma) at 37 8C in a 6% CO 2 incubator from days 1 to 3 (up to the eight-cell stage). Embryos were transferred to Sydney IVF blastocyst medium (COOK) for the remaining culture time. Each day embryos were removed from the incubator briefly and their developmental stage was noted.
Measurements of intracellular Ca 21
Fluorescence measurements were carried out on oocytes in drops of media in a heated chamber on the stage of a Zeiss Axiovert microscope equipped with epifluorescence optics and a 20 £ 0.75NA objective lens. Low-level fluorescence excitation was used to minimize oocyte damage. The light from a halogen lamp passed through a 490 nm bandpass filter and emission collected with a 510 nm longpass filter. Fluorescence light (100-1000 photons/s) was measured from each oocyte with an imaging photon detector (Photek Ltd, East Sussex, UK) using software and a system designed by Science Wares (Falmouth, MA, USA).
Results
Microinjection of human PLCz cRNA into aged human oocytes caused a series of Ca 2þ oscillations as indicated by the repetitive increases in the fluorescence of Oregon Green BAPTA dextran. Fig. 1 shows examples of the pattern of Ca 2þ oscillations triggered in different oocytes by injecting different concentrations of PLCz cRNA. The Ca 2þ oscillations consisted of series of sharp rises in Ca 2þ , followed by a fairly abrupt return to baseline Ca 2þ levels. There was then a very gradual increase in Ca 2þ before the next Ca 2þ rise suggesting the existence of a pacemaker that leads to another Ca 2þ increase every 10 min to 2 h (Fig. 1a) . This general pattern of Ca 2þ oscillations is similar to those reported after IVF or ICSI in human oocytes (Tesarik & Sousa 1994) , and broadly similar to the pattern of Ca 2þ oscillations seen in other mammals during fertilization (Swann & Ozil 1994) . The main difference between the patterns of oscillation was in regard to the frequency of Ca 2þ oscillations. In particular high concentrations of PLCz caused the highest-frequency oscillations. In addition we found that pipette concentrations of 1 or 10 mg/ml cRNA lead to oscillations that started with a relatively low frequency, but oscillations tended to show an increase in frequency with time such that the final frequency tended to match that seen with higher concentrations of PLCz cRNA (Fig. 1b) . A sustained low frequency of Ca 2þ oscillations was only seen when we injected pipette concentrations of approximately 0.1 mg/ml PLCz cRNA (Fig. 1c) . This concentration of PLCz cRNA also appeared to be the minimally effective concentration because only six out of 13 oocytes showed Ca 2þ responses. With pipette concentrations of 10 mg/ml or greater all the oocytes we injected underwent Ca 2þ oscillations. Table 1 shows the intervals of Ca 2þ oscillations seen after injecting different amounts of PLCz into human oocytes. Despite some changes in frequency with time at intermediate concentrations, there is a trend towards greater intervals between Ca 2þ increases with lower concentrations of injected PLCz cRNA. Since the amount of PLCz protein synthesized in mouse oocytes was shown to be proportional to the concentration of PLCz cRNA injected , these data suggest that the concentration of PLCz protein affects the frequency of Ca 2þ oscillations. As well as studying Ca 2þ oscillations we also examined groups of oocytes injected with PLCz for signs of activation. Since light exposure during fluorescence measurements can impair development, we carried out a separate set of experiments where PLCz cRNA was injected without monitoring Ca 2þ . In mice it is known that diploid parthenogenetic embryos have greater developmental potential than haploid embryos (Liu et al. 2002) . Consequently we treated oocytes with cytochalasin D (to block secondpolar-body emission) for the first 2 h following PLCz injection. When we injected oocytes with a pipette concentration of 10 mg/ml PLCz cRNA 10 out of 14 of them formed pronuclei, but only two embryos reached the two-cell stage where they then arrested (see Table 2 ). Previous experiments injecting human PLCz into mouse oocytes showed that high-frequency Ca 2þ oscillations lead to cleavage stage arrest , so it was possible that relatively poor development was due to the development of the later high-frequency responses seen in Fig. 1b . Accordingly we tested the developmental potential further by injecting oocytes with the lowest concentration that caused low frequency Ca 2þ oscillations in most oocytes. We injected oocytes with pipette concentrations of 0.1 mg/ml PLCz cRNA and found that more embryos reached the two-cell stage. Furthermore, some of these embryos developed further and we obtained four parthenogenetic blastocysts from the 24 injected oocytes (Table 2 ). These data suggest that injecting low concentrations of PLCz into aged human oocytes can activate development to the blastocyst stage.
Discussion
PLCz is a sperm-specific isoform of the PLC family of enzymes . Injection of PLCz as cRNA, or as a recombinant protein, has been shown to cause Ca 2þ oscillations and oocyte activation in the mouse , Kouchi et al. 2004 . PLCz protein has also been shown to be present in mammalian sperm at concentrations that are effective at causing Ca 2þ oscillations in mouse eggs. We have previously identified the human isoform of PLCz and showed that it causes prolonged Ca 2þ oscillations and the activation of development in mouse oocytes. The current data are the first to report that human PLCz is also highly effective at causing Ca 2þ oscillations in aged human oocytes. PLCz generates the Ca 2þ -releasing second messenger InsP 3 which has been shown to cause Ca 2þ release in human oocytes (Goud et al. 2002) . Our data therefore suggest that PLCz could be the protein from the sperm that is responsible for stimulating InsP 3 production and Ca 2þ oscillations and the activation of development in humans.
Our work also represents the first clear demonstration of a method for generating prolonged repetitive Ca 2þ signals in human oocytes. One study has reported the activation of aged human oocytes by applying three electrical-field pulses rather than one (Zhang et al. 1999) . However, the fertilized human oocyte clearly displays more than three Ca 2þ rises and extending this methodology requires rapid washing techniques that are technically demanding (Ozil 1990 ). Strontium-containing medium has been used to stimulate repetitive Ca 2þ increases in mouse eggs and might offer another simpler means of stimulating oscillations in human oocytes. However, we failed to observe any Ca 2þ transients when we incubated human oocytes in 10 mM Sr 2þ media (N Rodgers & K Swann, unpublished observations), and it remains uncertain whether Sr 2þ can be used for this purpose. Thimerosal is reported to cause Ca 2þ oscillation in human oocytes (Homa & Swann 1994 ), but as a thiol oxidizing agent it also effects the cytoskeleton and may not be compatible with human embryo development (Cheek et al. 1993) . Our current data with PLCz, therefore, provide perhaps one of the only relatively simple means of stimulating multiple and long-lasting Ca 2þ increases in human oocytes.
Previous work on mouse oocytes demonstrated that injecting cRNA encoding the human, mouse or monkey isoforms of PLCz could initiate Ca 2þ oscillations and activation of mouse oocytes . The injected cRNA is converted into PLCz protein in proportion to the amount of cRNA injected . The amount of human PLCz that caused Ca 2þ oscillations in aged human oocytes in this study is within a similar range to that which causes Ca 2þ oscillations in mouse oocytes . However, mouse oocytes were induced to undergo Ca 2þ oscillations by injection of final concentrations of approximately 1 ng/ml human PLCz cRNA, which is about 10 times lower than the amount that we used to generate Ca 2þ oscillations in aged human oocytes. This could mean that there are differences in sensitivity to PLCz between mouse and human oocytes. Nevertheless, it is also likely that aged human oocytes do not translate the cRNA into protein as efficiently as the recently ovulated mouse oocytes. We used the method of injecting cRNA, rather than PLCz protein, because of the unstable nature of the recombinant protein. Injecting the cRNA also provides a way of introducing PLCz into an There appears to be a narrow concentration range of PLCz that can be used to activate oocytes. The lowest concentrations of PLCz cRNA are not effective in all oocytes, but too high a concentration can lead to high-frequency Ca 2þ oscillations that appear to be detrimental to development beyond the two-cell stage . The low frequency of Ca 2þ oscillations that was consistent with reasonable rates of implantation development is similar to the low frequency of oscillations that were first reported using aequorin to measure Ca 2þ levels during human fertilization (Taylor et al. 1993) . Such low-frequency Ca 2þ oscillations during fertilization are also seen in the mouse when aequorin is used to measure Ca 2þ (Cuthbertson & Cobbold 1985) . In parallel experiments we found that a slightly greater proportion of oocytes activated (75%) than showed Ca 2þ oscillations (approximately 50%) when 0.1 mg/ml PLCz cRNA was injected. This could reflect the fact that Oregon Green BAPTA dextran buffers the Ca 2þ levels to some extent, and so a higher proportion of oocytes may actually undergo oscillations when Ca 2þ is not measured. In future it would be useful to measure Ca 2þ with less-invasive probes so that the same oocytes can be observed for Ca 2þ oscillations and development.
Whereas the overall numbers are small, our data are noteworthy in that development to the blastocyst stage was seen after artificial activation of aged human oocytes. Previous studies have reported the same parthenogenetic development to the blastocyst stage with freshly ovulated human oocytes (Cibelli et al. 2001 , Lin et al. 2003 . However, when using aged human oocytes the Ca 2þ -ionophore-based protocols have stimulated early cleavage stage development, but blastocyst formation has not been reported (Winston et al. 1991 , Balakier & Casper 1993 , Nakagawa et al. 2001 . It is possible that we obtained blastocysts in some cases because oocytes were stimulated with a repetitive Ca 2þ signal. However, more-extensive studies are required to make direct developmental comparisons between oocytes activated by PLCz compared with those stimulated by ionophore. Whatever the case our data do suggest that PLCz could be used to generate human parthenogenetic embryos and this in itself has clinical implications. First, there are clearly some cases where failed fertilization after ICSI is due to failed oocyte activation (Rawe et al. 2000) . In some cases embryo development and live births have been achieved after sperm injection by providing an activation stimulus in the form of Ca 2þ ionophore (Eldar-Geva et al. 2003 , Murase et al. 2004 . PLCz offers an alternative means by which failed activation may be restored with a more physiological stimulus than ionophore. Secondly, the generation of parthenogenetic blastocysts from oocytes can provide a source of embryos for the creation of stem cells (Lin et al. 2003 , Vrana et al. 2003 . The use of such parthenogentic embryos may be more ethically acceptable than using embryos from fertilized zygotes.
